Breaking Research News from Breastcancer.org
Comments
-
Hmmmm....so is there a study for women without genetic mutations that show the benefit of Breast MRI as a screening tool for early breast cancer? Surely, there is since only 5-10% of women dx with breast cancer have genetic mutation, but 1 in 8 women will develop breast cancer in their lifetime
0 -
Hi Chemokaze,
There are numerous Research News articles on the main Breastcancer.org site about Breast MRI that may help answer your question!
--The Mods
0 -
Does Processed Meat Increase Breast Cancer Risk?
October 5, 2018
A study suggests that eating processed meat is linked to a higher risk of breast cancer. Still, the study leaves many questions unanswered, and the researchers do not suggest that people stop eating processed meats. Read more...0 -
Study Shows Value of Second Opinions for Breast Cancer Diagnosis
October 5, 2018
A study strongly suggests that a second opinion can be very valuable for people diagnosed with breast cancer: more than 40% of people who asked for a second opinion had a change in diagnosis. Read more...0 -
Silicone Breast Implants Linked to Number of Complications, but FDA Critical of Study
October 5, 2018
A study suggests that silicone breast implants are associated with a higher risk of certain autoimmune disorders, as well as stillbirth and melanoma, but the FDA disagrees with the results. Read more...0 -
Black Women, Women Living in Poverty Less Likely to Recognize Barriers to Breast Cancer Screening, So They Don't Take Advantage of Patient Navigation for Optimal Care
October 9, 2018
Women who need patient navigation interventions the most are less likely to report barriers to optimal breast cancer screening care. Read more...0 -
Chemo Brain in Older Women May Be Linked to Specific Version of APOE Gene
October 11, 2018
Older women treated with chemotherapy and/or hormonal therapy had poorer cognitive skills compared to similar women who hadn't been diagnosed with breast cancer; women with the APOEe4 gene had the poorest post-treatment cognitive skills. Read more...0 -
FDA Approves Talzenna to Treat Metastatic Breast Cancer in Women With BRCA Mutations
October 17, 2018
The FDA has approved Talzenna (chemical name: talazoparib) to treat locally advanced or metastatic HER2-negative breast cancer in women with an inherited BRCA1 or BRCA2 mutation. Read more...0 -
Black Women Less Likely to Take Hormonal Therapy as Prescribed After Surgery for Breast Cancer
October 22, 2018
Compared to white women, black women diagnosed with early-stage, hormone-receptor-positive disease are less likely to take hormonal therapy every day, as prescribed, or to stop taking the medicine early. Read more...0 -
Immunotherapy Tecentriq Helps Treat Certain Advanced-Stage Triple-Negative Breast Cancers
October 24, 2018
Tecentriq, an immunotherapy medicine, combined with the targeted therapy Abraxane was better than Abraxane alone for people diagnosed with locally advanced or metastatic triple-negative breast cancer who had not been treated yet for advanced-stage disease. Read more...0 -
Adding Ibrance to Faslodex Improves Overall Survival in Advanced-Stage, Hormone-Receptor-Positive Breast Cancer
October 24, 2018
Latest results from the PALOMA-3 trial show adding Ibrance to Faslodex improves overall survival by about 7 months compared to Faslodex alone in women diagnosed with hormone-receptor-positive, HER2-negative advanced-stage breast cancer that had grown while being treated with hormonal therapy. Read more...0 -
Is 9 Weeks of Herceptin as Good as 1 Year of Herceptin?
October 29. 2018
While 9 weeks of Herceptin was associated with fewer heart problems compared to 1 year of Herceptin, the difference in disease-free survival was small and the researchers said 1 year of Herceptin should remain the standard of care. Read more...0 -
Breast Cancer Risk Assessment Tool Seems Accurate for 19 Years
October 29, 2018
A study has found that the Tyrer-Cuzick breast cancer risk assessment tool is accurate for at least 19 years. Read more...0 -
Mastectomy Doesn't Eliminate Need for Mammograms
October 30, 2018
Having a single or double mastectomy doesn't completely eliminate the need for breast imaging in the future. Read more...0 -
Many Women Report Paying Out-of-Pocket Costs for Routine Mammograms
October 30, 2018
More than 23% of women aged 50 to 64 and nearly 12% of women aged 65 to 74 reported paying a cost for their most recent mammogram. Read more...0 -
Women With Metastatic Breast Cancer Report "Catastrophic" Financial Effects
October 31, 2018
A national survey of more than 1,000 women diagnosed with metastatic breast cancer found that 35% had no insurance and nearly 70% said they were worried about financial problems because of cancer. Read more...0 -
Long-Term Results Suggest Fat Grafting Does Not Increase Recurrence Risk
October 31, 2018
A study suggests fat grafting breast reconstruction does not increase the risk of breast cancer recurrence compared to more traditional reconstruction techniques. Read more...0 -
Many Younger Women Don't Take Tamoxifen as Prescribed for Breast Cancer
November 1, 2018
The first study to look at adherence to hormonal therapy among younger women found that more than 18% were not taking the medicine as prescribed. Read more...0 -
Radiation Therapy After Surgery for Low-Risk DCIS Reduces Recurrence Risk
November 1, 2018
Radiation therapy after lumpectomy to remove low-risk DCIS reduces the risk of recurrence, but had no effect on overall survival. Read more...0 -
No Increase in Long-Term Side Effects With Weekly Hypofractionated Radiation Schedule
November 2, 2018
After lumpectomy for early-stage breast cancer, an accelerated radiation therapy schedule of treatment once per week for 5 weeks offers about the same rate of long-term side effects as a traditional schedule of daily treatment for 5 weeks. Read more...0 -
No Increase in Long-Term Side Effects With Weekly Hypofractionated Radiation Schedule
November 2, 2018
After lumpectomy for early-stage breast cancer, an accelerated radiation therapy schedule of treatment once per week for 5 weeks offers about the same rate of long-term side effects as a traditional schedule of daily treatment for 5 weeks. Read more...0 -
Experimental Alpelisib May Help Treat Advanced-Stage, Hormone-Receptor-Positive, HER2-Negative Breast Cancer With Specific Mutation
November 6, 2018
Experimental alpelisib combined with Faslodex improved progression-free survival more than Faslodex alone in people diagnosed with advanced-stage, hormone-receptor-positive, HER2-negative breast cancer with a PIK3CA mutation. Read more...0 -
Zoladex Helps Preserve Fertility in Women With Early-Stage, Hormone-Receptor-Negative Breast Cancer Treated With Chemotherapy
November 9, 2018
Five-year results found women diagnosed with early-stage, hormone-receptor-negative breast cancer who were treated with Zoladex in addition to chemotherapy before surgery were much less likely to be infertile after chemotherapy ended. Read more...0 -
Zometa Plus Femara Seems Better Than Tamoxifen for Premenopausal Women With Hormone-Receptor-Positive Breast Cancer, but Causes More Side Effects
November 13, 2018
The combination of Zometa and Femara after surgery offered better disease-free survival than tamoxifen for premenopausal women diagnosed with early-stage, hormone-receptor-positive breast cancer, but caused more side effects. Read more...0 -
Cold Therapy May Help Prevent Hair Loss, Skin, Nail Side Effects Caused by Taxane Chemotherapy
November 13, 2018
A meta-analysis suggests that cold therapy — including cold caps, frozen gloves, and frozen socks — can help prevent some of the hair loss, as well as skin and nail side effects, caused by taxane chemotherapy. Read more...0 -
Regular Screening Reduces Risk of Dying From Breast Cancer
November 14, 2018
Women diagnosed with breast cancer who had regular mammograms had a 60% lower risk of dying from the disease in the 10 years after diagnosis and a 47% lower risk of dying from the disease in the 20 years after diagnosis compared to women who didn't have regular screening. Read more...0 -
Large Breasts, Chemotherapy Don't Seem to Rule Out Hypofractionated Radiation Schedule
November 14, 2018
A study suggests that a tumor bed radiation boost, chemotherapy, and/or larger breast size don't mean that a person shouldn't be treated with hypofractionated whole-breast radiation after lumpectomy. Read more...0 -
Women 75 and Older Benefit From Screening Mammograms
November 27, 2018
While women 75 and older made up a relatively small percentage of the breast cancer screening population (about 10%), women diagnosed with breast cancer in this age group made up 16% of all women diagnosed with screening-detected cancers. Read more...0 -
Updated ASCO Guidelines Recommend Extended Hormonal Therapy With Aromatase Inhibitors for Postmenopausal Women With Hormone-Receptor-Positive Breast Cancer
November 29, 2018
ASCO has updated its guidelines on adjuvant hormonal therapy, recommending postmenopausal women diagnosed with early-stage, node-positive, hormone-receptor-positive breast cancer be treated with hormonal therapy, including an aromatase inhibitor, for 10 years after surgery. Read more...0 -
Latissimus Dorsi Flap Reconstruction Seems to Cause Biggest Loss in Shoulder Stability, Function
December 3, 2018
Compared to DIEP flap reconstruction and implant reconstruction, latissimus dorsi flap reconstruction caused the greatest loss of shoulder function, strength, and mobility. Read more...0
